APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Based on Gene Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug Based on Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17398610032 January 2026191 pages

Choose your research edition.

Industry ResearchDrug Based on Gene Therapy Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Based on Gene Therapy Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Drug Based on Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Based on Gene Therapy Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Based on Gene Therapy Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Drug Based on Gene Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drug Based on Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Based on Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Based on Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Based on Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Based on Gene Therapy include Novartis, Biogen, Amgen, Sunway Biotech, Spark Therapeutics, SIBIONO, Sarepta Therapeutics, Orchard Therapeutics and Human Stem Cells Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drug Based on Gene Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Based on Gene Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Based on Gene Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug Based on Gene Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Based on Gene Therapy Segment by Company

Novartis

Biogen

Amgen

Sunway Biotech

Spark Therapeutics

SIBIONO

Sarepta Therapeutics

Orchard Therapeutics

Human Stem Cells Institute

Gilead Sciences

bluebird bio

AnGes

Alnylam Pharmaceuticals

Akcea Therapeutics

Drug Based on Gene Therapy Segment by Type

Viral Gene Therapy

Non-viral Gene Therapy

Drug Based on Gene Therapy Segment by Application

Neurological Diseases

Cancer

Other

Drug Based on Gene Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Based on Gene Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Based on Gene Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Based on Gene Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug Based on Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Based on Gene Therapy industry.

Chapter 3: Detailed analysis of Drug Based on Gene Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Based on Gene Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Based on Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Viral Gene Therapy Table 3. Key Players of Non-viral Gene Therapy Table 4. Global Drug Based on Gene Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Neurological Diseases Table 6. Key Players of Cancer Table 7. Key Players of Other Table 8. Global Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Drug Based on Gene Therapy Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Drug Based on Gene Therapy Market Share by Region (2021-2026) Table 11. Global Drug Based on Gene Therapy Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Drug Based on Gene Therapy Market Share by Region (2027-2032) Table 13. Drug Based on Gene Therapy Industry Trends Table 14. Drug Based on Gene Therapy Industry Drivers Table 15. Drug Based on Gene Therapy Industry Opportunities and Challenges Table 16. Drug Based on Gene Therapy Industry Restraints Table 17. Global Drug Based on Gene Therapy Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Drug Based on Gene Therapy Revenue Market Share by Company (2021-2026) Table 19. Global Drug Based on Gene Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Drug Based on Gene Therapy Key Company Head Office and Area Served Table 21. Global Drug Based on Gene Therapy Company, Product Type & Application Table 22. Global Drug Based on Gene Therapy Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Drug Based on Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Drug Based on Gene Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drug Based on Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Drug Based on Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Drug Based on Gene Therapy Revenue Market Share by Type (2021-2026) Table 29. Global Drug Based on Gene Therapy Revenue Market Share by Type (2027-2032) Table 30. Global Drug Based on Gene Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Drug Based on Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Drug Based on Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Drug Based on Gene Therapy Revenue Market Share by Application (2021-2026) Table 34. Global Drug Based on Gene Therapy Revenue Market Share by Application (2027-2032) Table 35. Novartis Company Information Table 36. Novartis Business Overview Table 37. Novartis Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Novartis Drug Based on Gene Therapy Product Portfolio Table 39. Novartis Recent Development Table 40. Biogen Company Information Table 41. Biogen Business Overview Table 42. Biogen Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Biogen Drug Based on Gene Therapy Product Portfolio Table 44. Biogen Recent Development Table 45. Amgen Company Information Table 46. Amgen Business Overview Table 47. Amgen Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Amgen Drug Based on Gene Therapy Product Portfolio Table 49. Amgen Recent Development Table 50. Sunway Biotech Company Information Table 51. Sunway Biotech Business Overview Table 52. Sunway Biotech Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sunway Biotech Drug Based on Gene Therapy Product Portfolio Table 54. Sunway Biotech Recent Development Table 55. Spark Therapeutics Company Information Table 56. Spark Therapeutics Business Overview Table 57. Spark Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Spark Therapeutics Drug Based on Gene Therapy Product Portfolio Table 59. Spark Therapeutics Recent Development Table 60. SIBIONO Company Information Table 61. SIBIONO Business Overview Table 62. SIBIONO Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. SIBIONO Drug Based on Gene Therapy Product Portfolio Table 64. SIBIONO Recent Development Table 65. Sarepta Therapeutics Company Information Table 66. Sarepta Therapeutics Business Overview Table 67. Sarepta Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sarepta Therapeutics Drug Based on Gene Therapy Product Portfolio Table 69. Sarepta Therapeutics Recent Development Table 70. Orchard Therapeutics Company Information Table 71. Orchard Therapeutics Business Overview Table 72. Orchard Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Orchard Therapeutics Drug Based on Gene Therapy Product Portfolio Table 74. Orchard Therapeutics Recent Development Table 75. Human Stem Cells Institute Company Information Table 76. Human Stem Cells Institute Business Overview Table 77. Human Stem Cells Institute Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Human Stem Cells Institute Drug Based on Gene Therapy Product Portfolio Table 79. Human Stem Cells Institute Recent Development Table 80. Gilead Sciences Company Information Table 81. Gilead Sciences Business Overview Table 82. Gilead Sciences Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Gilead Sciences Drug Based on Gene Therapy Product Portfolio Table 84. Gilead Sciences Recent Development Table 85. bluebird bio Company Information Table 86. bluebird bio Business Overview Table 87. bluebird bio Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. bluebird bio Drug Based on Gene Therapy Product Portfolio Table 89. bluebird bio Recent Development Table 90. AnGes Company Information Table 91. AnGes Business Overview Table 92. AnGes Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. AnGes Drug Based on Gene Therapy Product Portfolio Table 94. AnGes Recent Development Table 95. Alnylam Pharmaceuticals Company Information Table 96. Alnylam Pharmaceuticals Business Overview Table 97. Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Portfolio Table 99. Alnylam Pharmaceuticals Recent Development Table 100. Akcea Therapeutics Company Information Table 101. Akcea Therapeutics Business Overview Table 102. Akcea Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Akcea Therapeutics Drug Based on Gene Therapy Product Portfolio Table 104. Akcea Therapeutics Recent Development Table 105. North America Drug Based on Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Drug Based on Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Drug Based on Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Drug Based on Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Drug Based on Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Drug Based on Gene Therapy Market Size by Country (2021-2026) Table 111. North America Drug Based on Gene Therapy Market Size by Country (2027-2032) Table 112. Europe Drug Based on Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Drug Based on Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Drug Based on Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Drug Based on Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Drug Based on Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Drug Based on Gene Therapy Market Size by Country (2021-2026) Table 118. Europe Drug Based on Gene Therapy Market Size by Country (2027-2032) Table 119. China Drug Based on Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 120. China Drug Based on Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 121. China Drug Based on Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 122. China Drug Based on Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Drug Based on Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Drug Based on Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Drug Based on Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Drug Based on Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Drug Based on Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Drug Based on Gene Therapy Market Size by Country (2021-2026) Table 129. Asia Drug Based on Gene Therapy Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Drug Based on Gene Therapy Product Image Figure 2. Global Drug Based on Gene Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drug Based on Gene Therapy Market Share by Type: 2025 VS 2032 Figure 4. Viral Gene Therapy Image Figure 5. Non-viral Gene Therapy Image Figure 6. Global Drug Based on Gene Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Drug Based on Gene Therapy Market Share by Application: 2025 VS 2032 Figure 8. Neurological Diseases Image Figure 9. Cancer Image Figure 10. Other Image Figure 11. Global Drug Based on Gene Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 13. Global Drug Based on Gene Therapy Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Drug Based on Gene Therapy Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Drug Based on Gene Therapy Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drug Based on Gene Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Based on Gene Therapy Revenue Market Share by Type (2021-2032) Figure 20. Global Drug Based on Gene Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drug Based on Gene Therapy Revenue Market Share by Application (2021-2032) Figure 22. North America Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 23. North America Drug Based on Gene Therapy Market Share by Type (2021-2032) Figure 24. North America Drug Based on Gene Therapy Market Share by Application (2021-2032) Figure 25. North America Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 26. United States Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 27. Canada Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Europe Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Europe Drug Based on Gene Therapy Market Share by Type (2021-2032) Figure 31. Europe Drug Based on Gene Therapy Market Share by Application (2021-2032) Figure 32. Europe Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 33. Germany Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 34. France Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 36. Italy Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Russia Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 39. China Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 40. China Drug Based on Gene Therapy Market Share by Type (2021-2032) Figure 41. China Drug Based on Gene Therapy Market Share by Application (2021-2032) Figure 42. Asia Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 43. Asia Drug Based on Gene Therapy Market Share by Type (2021-2032) Figure 44. Asia Drug Based on Gene Therapy Market Share by Application (2021-2032) Figure 45. Asia Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 46. Japan Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 50. India Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 51. Australia Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Drug Based on Gene Therapy Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Drug Based on Gene Therapy Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 56. Brazil Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 61. UAE Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Chile Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Therapy
  • Non-viral Gene Therapy
Applications
  • Neurological Diseases
  • Cancer
  • Other
Companies covered
  • Novartis
  • Biogen
  • Amgen
  • Sunway Biotech
  • Spark Therapeutics
  • SIBIONO
  • Sarepta Therapeutics
  • Orchard Therapeutics
  • Human Stem Cells Institute
  • Gilead Sciences
  • bluebird bio
  • AnGes
  • Alnylam Pharmaceuticals
  • Akcea Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drug Based on Gene Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Viral Gene Therapy
  5. 1.2.3 Non-viral Gene Therapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Drug Based on Gene Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Neurological Diseases
  9. 1.3.3 Cancer
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Drug Based on Gene Therapy Growth Trends by Region
  13. 1.5.1 Global Drug Based on Gene Therapy Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Drug Based on Gene Therapy Market Size by Region (2021-2026)
  15. 1.5.3 Drug Based on Gene Therapy Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Drug Based on Gene Therapy Market Dynamics
  1. 2.1 Drug Based on Gene Therapy Industry Trends
  2. 2.2 Drug Based on Gene Therapy Industry Drivers
  3. 2.3 Drug Based on Gene Therapy Industry Opportunities and Challenges
  4. 2.4 Drug Based on Gene Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drug Based on Gene Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Drug Based on Gene Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drug Based on Gene Therapy Key Company Head office and Area Served
  4. 3.4 Global Drug Based on Gene Therapy Company, Product Type & Application
  5. 3.5 Global Drug Based on Gene Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drug Based on Gene Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drug Based on Gene Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drug Based on Gene Therapy Tier 1, Tier 2, and Tier 3
4 Drug Based on Gene Therapy Market by Type
  1. 4.1 Global Drug Based on Gene Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drug Based on Gene Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Drug Based on Gene Therapy Market Size Share by Type (2021-2032)
5 Drug Based on Gene Therapy Market by Application
  1. 5.1 Global Drug Based on Gene Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Based on Gene Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Drug Based on Gene Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Drug Based on Gene Therapy Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Biogen
  8. 6.2.1 Biogen Company Information
  9. 6.2.2 Biogen Business Overview
  10. 6.2.3 Biogen Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Biogen Drug Based on Gene Therapy Product Portfolio
  12. 6.2.5 Biogen Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amgen Drug Based on Gene Therapy Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Sunway Biotech
  20. 6.4.1 Sunway Biotech Company Information
  21. 6.4.2 Sunway Biotech Business Overview
  22. 6.4.3 Sunway Biotech Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sunway Biotech Drug Based on Gene Therapy Product Portfolio
  24. 6.4.5 Sunway Biotech Recent Developments
  25. 6.5 Spark Therapeutics
  26. 6.5.1 Spark Therapeutics Company Information
  27. 6.5.2 Spark Therapeutics Business Overview
  28. 6.5.3 Spark Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Spark Therapeutics Drug Based on Gene Therapy Product Portfolio
  30. 6.5.5 Spark Therapeutics Recent Developments
  31. 6.6 SIBIONO
  32. 6.6.1 SIBIONO Company Information
  33. 6.6.2 SIBIONO Business Overview
  34. 6.6.3 SIBIONO Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 SIBIONO Drug Based on Gene Therapy Product Portfolio
  36. 6.6.5 SIBIONO Recent Developments
  37. 6.7 Sarepta Therapeutics
  38. 6.7.1 Sarepta Therapeutics Company Information
  39. 6.7.2 Sarepta Therapeutics Business Overview
  40. 6.7.3 Sarepta Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Sarepta Therapeutics Drug Based on Gene Therapy Product Portfolio
  42. 6.7.5 Sarepta Therapeutics Recent Developments
  43. 6.8 Orchard Therapeutics
  44. 6.8.1 Orchard Therapeutics Company Information
  45. 6.8.2 Orchard Therapeutics Business Overview
  46. 6.8.3 Orchard Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Orchard Therapeutics Drug Based on Gene Therapy Product Portfolio
  48. 6.8.5 Orchard Therapeutics Recent Developments
  49. 6.9 Human Stem Cells Institute
  50. 6.9.1 Human Stem Cells Institute Company Information
  51. 6.9.2 Human Stem Cells Institute Business Overview
  52. 6.9.3 Human Stem Cells Institute Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Human Stem Cells Institute Drug Based on Gene Therapy Product Portfolio
  54. 6.9.5 Human Stem Cells Institute Recent Developments
  55. 6.10 Gilead Sciences
  56. 6.10.1 Gilead Sciences Company Information
  57. 6.10.2 Gilead Sciences Business Overview
  58. 6.10.3 Gilead Sciences Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Gilead Sciences Drug Based on Gene Therapy Product Portfolio
  60. 6.10.5 Gilead Sciences Recent Developments
  61. 6.11 bluebird bio
  62. 6.11.1 bluebird bio Company Information
  63. 6.11.2 bluebird bio Business Overview
  64. 6.11.3 bluebird bio Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 bluebird bio Drug Based on Gene Therapy Product Portfolio
  66. 6.11.5 bluebird bio Recent Developments
  67. 6.12 AnGes
  68. 6.12.1 AnGes Company Information
  69. 6.12.2 AnGes Business Overview
  70. 6.12.3 AnGes Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 AnGes Drug Based on Gene Therapy Product Portfolio
  72. 6.12.5 AnGes Recent Developments
  73. 6.13 Alnylam Pharmaceuticals
  74. 6.13.1 Alnylam Pharmaceuticals Company Information
  75. 6.13.2 Alnylam Pharmaceuticals Business Overview
  76. 6.13.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Portfolio
  78. 6.13.5 Alnylam Pharmaceuticals Recent Developments
  79. 6.14 Akcea Therapeutics
  80. 6.14.1 Akcea Therapeutics Company Information
  81. 6.14.2 Akcea Therapeutics Business Overview
  82. 6.14.3 Akcea Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Akcea Therapeutics Drug Based on Gene Therapy Product Portfolio
  84. 6.14.5 Akcea Therapeutics Recent Developments
7 North America
  1. 7.1 North America Drug Based on Gene Therapy Market Size (2021-2032)
  2. 7.2 North America Drug Based on Gene Therapy Market Size by Type
  3. 7.2.1 North America Drug Based on Gene Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Drug Based on Gene Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Drug Based on Gene Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Drug Based on Gene Therapy Market Size by Application
  7. 7.3.1 North America Drug Based on Gene Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Drug Based on Gene Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Drug Based on Gene Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Drug Based on Gene Therapy Market Size by Country
  11. 7.4.1 North America Drug Based on Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drug Based on Gene Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Drug Based on Gene Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Drug Based on Gene Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drug Based on Gene Therapy Market Size (2021-2032)
  2. 8.2 Europe Drug Based on Gene Therapy Market Size by Type
  3. 8.2.1 Europe Drug Based on Gene Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drug Based on Gene Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drug Based on Gene Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Drug Based on Gene Therapy Market Size by Application
  7. 8.3.1 Europe Drug Based on Gene Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drug Based on Gene Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drug Based on Gene Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Drug Based on Gene Therapy Market Size by Country
  11. 8.4.1 Europe Drug Based on Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drug Based on Gene Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drug Based on Gene Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drug Based on Gene Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drug Based on Gene Therapy Market Size (2021-2032)
  2. 9.2 China Drug Based on Gene Therapy Market Size by Type
  3. 9.2.1 China Drug Based on Gene Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Drug Based on Gene Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Drug Based on Gene Therapy Market Share by Type (2021-2032)
  6. 9.3 China Drug Based on Gene Therapy Market Size by Application
  7. 9.3.1 China Drug Based on Gene Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Drug Based on Gene Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Drug Based on Gene Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drug Based on Gene Therapy Market Size (2021-2032)
  2. 10.2 Asia Drug Based on Gene Therapy Market Size by Type
  3. 10.2.1 Asia Drug Based on Gene Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drug Based on Gene Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drug Based on Gene Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Drug Based on Gene Therapy Market Size by Application
  7. 10.3.1 Asia Drug Based on Gene Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drug Based on Gene Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drug Based on Gene Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Drug Based on Gene Therapy Market Size by Country
  11. 10.4.1 Asia Drug Based on Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drug Based on Gene Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drug Based on Gene Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drug Based on Gene Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drug Based on Gene Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drug Based on Gene Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drug Based on Gene Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drug Based on Gene Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst